Table 4. Distribution of the Sample (N = 4,205), by Results of Screening and Eligibility for Referral to Follow-Up Steps, Participants in a Cardiovascular Screening Pilot Phase in Lebanon, 2012–2013.
| Cardiovascular Risk Groups | Men (n = 1,422), n (%) | Women (n = 2,783) , n (%) | Total (N = 4,205) , n (%) |
|---|---|---|---|
| Referred to diagnostic step | 464 (32.6) | 571 (20.5) | 1,035 (24.6) |
| TCVR ≥10% and metabolic impairment | 112 (7.9) | 139 (5.0) | 251 (6.0) |
| Only TCVR score ≥10% | 26 (1.8) | 0 | 26 (0.6) |
| Only metabolic impairment | 326 (22.9) | 432 (15.5) | 758 (18.0) |
| Not referred to diagnostic step | 958 (67.4) | 2,212 (79.5) | 3,170 (75.4) |
| Metabolically unimpaired obesea | 306 (21.5) | 1,230 (44.2) | 1,536 (36.5) |
| Nonobese, metabolically unimpaired smokers | 317 (22.3) | 393 (14.1) | 710 (16.9) |
| No risk factors detected | 335 (23.6) | 589 (21.2) | 924 (22.0) |
Abbreviation: TCVR, total cardiovascular risk.
a
Indexed as body mass index ≥30 or substantially elevated waist circumference (waistline ≥94 cm in men and ≥88 cm in women) or both.